ArticleVaccine2009

A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity.

Rich-Henry Schabowsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.